New developments in the treatment of colorectal malignancies
New developments in the treatment of colorectal malignancies
Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly with relapsed/refractory large B-cell lymphoma
Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer
Isatuximab + Kd in RRMM: Depth of Response Results From the IKEMA Trial
War in Ukraine: Global cancer aid to support refugees
War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis
Ibrutinib plus venetoclax for 1-L treatment of CLL and small lymphocytic lymphoma shows a clinically meaningful PFS
Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian cancer
RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies
Comment: Addition of ixazomib to pomalidomide and dexamethasone improves survival for multiple myeloma patients
A bispecific antibody talquetamab shows promising efficacy in relapsed/refractory multiple myeloma
Isatuximab, lenalidomide, bortezomib and dexamethasone as induction therapy show a superior MRD negativity rate for newly diagnosed MM patients